South Korea showcases top 10 innovative medical devices at annual report meeting South Korea reveals its top ten groundbreaking healthcare technologies at a major annual event ...
Securing FDA clearance or approval is a major accomplishment for medical device and pharmaceutical companies, but it’s not ...
AB (market cap: $16.28M), a company in the development stage, provided insights into its Q4 2024 performance and future plans during its recent earnings call. The company is advancing its Neola ...
NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET ...
Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...
Hosted on MSN1d
Biocurious: Hut Hut Hut! The growing list of ASX biotechs waiting for the FDA to call the start of playA large number of Australian biotechs are waiting for US FDA product approval – or are on the cusp of ... Read More The post ...
After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...
Insurers were supposed to start covering recreational prosthetics on Jan. 1, but the state is still deciding how to implement the law ...
For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...
In wrapping up the 2023-24 term and embarking on the 2024-25 term, the Supreme Court was asked to decide a number of intellectual property cases. The ...
Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback